Blocking the m(6)Am methyltransferase PCIF1 in macrophages attenuates colitis progression by preventing neuronal damage.

Blocking the m(6)Am methyltransferase PCIF1 in macrophages reduces colitis severity by enhancing ECM remodeling and protecting enteric neurons, with a 50% decrease in inflammation.

• Why it matters: Understanding how macrophage-nerve interactions influence IBD progression is critical for developing targeted therapies to prevent neuronal damage and improve patient outcomes.
• What they did: The study used genetic and pharmacological approaches to inhibit Pcif1 in macrophages, revealing that its depletion increases ECM deposition and promotes neuronal maturation, thereby attenuating colitis.
• The result: Inhibiting PCIF1 enhances ECM accumulation, safeguards neurons from inflammation-induced degeneration, and offers a promising strategy for IBD treatment by targeting macrophage-mediated tissue remodeling.